Reversal of acquired hepatocerebral degeneration with living donor liver transplantation
Shayon D. Salehi, Debbie L. Shawcross – 26 February 2016
Assessing the risk of bleeding and clotting in cirrhosis
Neeral L. Shah, Stephen H. Caldwell – 26 February 2016
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Pranab M. Barman, Grace L. Su – 26 February 2016
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Pranab M. Barman, Grace L. Su – 26 February 2016
Liver transplantation for hepatocellular carcinoma
Mohannad F. Dugum, Nizar N. Zein – 26 February 2016
Liver transplantation for hepatocellular carcinoma
Mohannad F. Dugum, Nizar N. Zein – 26 February 2016
Treatment options of patients with chronic hepatitis C who have failed prior therapy
- Read more about Treatment options of patients with chronic hepatitis C who have failed prior therapy
Neil D. Shah, Michael W. Fried – 26 February 2016
Liver transplantation for adenomatosis: European experience
Laurence Chiche, Anaelle David, René Adam, M. Martin Oliverius, Jürgen Klempnauer, Eric Vibert, Michele Colledan, Jan Lerut, V.
A prospective study of a protocol that reduces readmission after liver transplantation
Mark W. Russo, David M. Levi, Ruth Pierce, Vincent Casingal, Lon Eskind, Andrew deLemos, Paul A. Schmeltzer, Philippe J. Zamor – 26 February 2016 – Health care has shifted to placing priority on quality and value instead of volume. Liver transplantation uses substantial resources and is associated with high readmission rates. Our goal was to determine if a protocol designed to reduce readmission after liver transplant was effective.
Editorial Board
25 February 2016